Market revenue in 2023 | USD 53.3 million |
Market revenue in 2030 | USD 79.8 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Detection of latent infection (skin test & igra) |
Fastest growing segment | Detection of Drug Resistance (DST) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nucleic Acid Testing, Detection of Latent Infection (Skin Test & IGRA), Detection of Drug Resistance (DST), Other Methods, Phage Assay, Cytokine Detection Assay, Diagnostic Laboratory Methods, Radiographic Method |
Key market players worldwide | Abbott Laboratories, Becton Dickinson & Co, Roche Holding AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, Qiagen NV, Hologic Inc, BD, Hain Lifescience, Cepheid |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tuberculosis diagnostics market will help companies and investors design strategic landscapes.
Detection of latent infection (skin test & igra) was the largest segment with a revenue share of 41.28% in 2023. Horizon Databook has segmented the Brazil tuberculosis diagnostics market based on nucleic acid testing, detection of latent infection (skin test & igra), detection of drug resistance (dst), other methods, phage assay, cytokine detection assay, diagnostic laboratory methods, radiographic method covering the revenue growth of each sub-segment from 2018 to 2030.
Growing healthcare expenditure by the government is expected to play a positive role in the market progress. Market growth is attributed to supportive government initiatives, such as Sistema Unico de Saude (SUS), the public health system that covers health insurance for all citizens in Brazil.
Owing to the moderate standards of living, prevalence of infectious diseases is comparatively high in the country, which fosters the screening rate for TB.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil tuberculosis diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil tuberculosis diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account